NO20024623L - Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform - Google Patents

Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform

Info

Publication number
NO20024623L
NO20024623L NO20024623A NO20024623A NO20024623L NO 20024623 L NO20024623 L NO 20024623L NO 20024623 A NO20024623 A NO 20024623A NO 20024623 A NO20024623 A NO 20024623A NO 20024623 L NO20024623 L NO 20024623L
Authority
NO
Norway
Prior art keywords
preparation
crystal form
novel process
new crystal
imidazopyridine derivative
Prior art date
Application number
NO20024623A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024623D0 (no
Inventor
Fumihiko Matsubara
Takashi Ohya
Masaaki Uenaka
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO20024623D0 publication Critical patent/NO20024623D0/no
Publication of NO20024623L publication Critical patent/NO20024623L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20024623A 2000-03-30 2002-09-26 Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform NO20024623L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000092565 2000-03-30
PCT/JP2001/002620 WO2001074821A1 (fr) 2000-03-30 2001-03-29 Nouveau procede de production de derive d'imidazopyridine fondu et nouvelle forme cristalline

Publications (2)

Publication Number Publication Date
NO20024623D0 NO20024623D0 (no) 2002-09-26
NO20024623L true NO20024623L (no) 2002-11-08

Family

ID=18607880

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024623A NO20024623L (no) 2000-03-30 2002-09-26 Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform

Country Status (17)

Country Link
US (1) US7049437B2 (fr)
EP (1) EP1270578A4 (fr)
JP (1) JP3481930B2 (fr)
KR (1) KR20020082898A (fr)
CN (1) CN1203073C (fr)
AU (1) AU2001244613A1 (fr)
BR (1) BR0109643A (fr)
CA (1) CA2403131A1 (fr)
CZ (1) CZ20023276A3 (fr)
HK (1) HK1054387A1 (fr)
HU (1) HUP0300580A3 (fr)
IL (1) IL151877A0 (fr)
MX (1) MXPA02009460A (fr)
NO (1) NO20024623L (fr)
PL (1) PL357672A1 (fr)
WO (1) WO2001074821A1 (fr)
ZA (1) ZA200207295B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003008421A1 (fr) * 2001-07-16 2003-01-30 Shionogi & Co., Ltd. Procede de preparation de derives amidine
JPWO2004078173A1 (ja) * 2003-02-05 2006-06-08 塩野義製薬株式会社 溶出性の改善された錠剤
WO2005018556A2 (fr) 2003-08-12 2005-03-03 3M Innovative Properties Company Composes contenant une structure imidazo a substitution hydroxylamine
ES2406730T3 (es) 2003-08-27 2013-06-07 3M Innovative Properties Company Imidazoquinolinas sustituidas con ariloxi y arilalquilenoxi
AU2004270201A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2540541C (fr) 2003-10-03 2012-03-27 3M Innovative Properties Company Imidazoquinolines a substitution alcoxy
WO2005048945A2 (fr) * 2003-11-14 2005-06-02 3M Innovative Properties Company Composes d'un anneau d'imidazo substitue par hydroxylamine
EP1685129A4 (fr) 2003-11-14 2008-10-22 3M Innovative Properties Co Composes d'un anneau d'imidazo substitues par oxime
JP4891088B2 (ja) 2003-11-25 2012-03-07 スリーエム イノベイティブ プロパティズ カンパニー 置換されたイミダゾ環系および方法
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
CA2551399A1 (fr) 2003-12-30 2005-07-21 3M Innovative Properties Company Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle
CA2559863A1 (fr) 2004-03-24 2005-10-13 3M Innovative Properties Company Imidazopyridines, imidazoquinolines, et imidazonaphthyridines a substitution amide
WO2005094770A1 (fr) * 2004-03-30 2005-10-13 Unilever Plc Compositions pour eclaircir la peau comprenant des vitamines et des flavonoides
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006009832A1 (fr) * 2004-06-18 2006-01-26 3M Innovative Properties Company Systemes cycliques imidazo substitues, et procedes correspondants
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006038923A2 (fr) 2004-06-18 2006-04-13 3M Innovative Properties Company Imidazonaphthyridines substituees par aryle
AU2005322898B2 (en) 2004-12-30 2011-11-24 3M Innovative Properties Company Chiral fused (1,2)imidazo(4,5-c) ring compounds
AU2005326708C1 (en) 2004-12-30 2012-08-30 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
CA2597092A1 (fr) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Formulations des gel aqueux contenant des modificateurs de reponse immunitaire
WO2006086634A2 (fr) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes
EP1869043A2 (fr) 2005-04-01 2007-12-26 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines et analogues associes
CA2602590A1 (fr) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Composes cycliques 1-pyrazolo[3,4-c] substitues comme modulateurs de la biosynthese de cytokine destines au traitement d'infections virales et de maladies neoplastiques
KR20080048551A (ko) * 2005-09-23 2008-06-02 콜레이 파마시티컬 그룹, 인코포레이티드 1H-이미다조[4,5-c]피리딘 및 그의 유사체의 제조법
WO2008008432A2 (fr) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants
FI3856341T3 (fi) 2019-04-12 2023-11-30 Blueprint Medicines Corp (s)-1-(4-fluorifenyyli)-1-(2-(4-(6-(1-metyyli-1h-pyratsol-4-yyli)pyrrolo[2,1-f][1,2,4]triatsin-4-yyli)piperatsinyyli)pyrimidin-5-yyli)etaani-1-amiinin kidemuotoja ja valmistusmenetelmiä

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378848A (en) * 1992-02-12 1995-01-03 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them

Also Published As

Publication number Publication date
JP3481930B2 (ja) 2003-12-22
CZ20023276A3 (cs) 2003-02-12
CA2403131A1 (fr) 2001-10-11
EP1270578A4 (fr) 2004-11-03
HUP0300580A3 (en) 2006-06-28
US20030088102A1 (en) 2003-05-08
PL357672A1 (en) 2004-07-26
AU2001244613A1 (en) 2001-10-15
HK1054387A1 (zh) 2003-11-28
NO20024623D0 (no) 2002-09-26
ZA200207295B (en) 2003-09-11
BR0109643A (pt) 2003-04-22
CN1203073C (zh) 2005-05-25
HUP0300580A2 (hu) 2003-07-28
US7049437B2 (en) 2006-05-23
MXPA02009460A (es) 2003-02-12
KR20020082898A (ko) 2002-10-31
CN1419557A (zh) 2003-05-21
EP1270578A1 (fr) 2003-01-02
WO2001074821A1 (fr) 2001-10-11
IL151877A0 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
NO20024623L (no) Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform
NO20030844L (no) Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20031694L (no) Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
NO20022176D0 (no) Absorberende gjenstand og fremgangsmåte for fremstilling av denne
NO20032518D0 (no) Fremgangsmåte for fremstilling av amlodipinmaleat
CY2009001I2 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20013942D0 (no) Fremgangsmate for fremstilling av Citalopram
NO20023950L (no) Fremgangsmåte for fremstilling av en titanholdig zeolitt
NO20024321D0 (no) Fremgangsmåte for fremstilling av krystallinsk form I av kabergolin
NO20021124D0 (no) Fremgangsmåte for fremstilling av benzoksazinderivater og mellomprodukter derfor
NO20031413L (no) Ny fremgangsmate for fremstilling av oksabispidiner og nytt mellomprodukt
NO20003555L (no) Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer
NO20025069D0 (no) Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20023973L (no) Fremgangsmåte for fremstilling av en titanholdig zeolitt
DK1339723T3 (da) Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20023577L (no) Fremgangsmåte for fremstilling av acetyl-amidinofenylalanyl- cykloheksylglycyl-pyridinioalaninamider
NO20030587L (no) Fremgangsmåte til fremstilling av diskodermolid og analoger derav
NO20032297L (no) Fremgangsmåte for fremstilling av distamycinderivater
NO20023702L (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application